table of content
1 Introduction to Research & Analysis Reports
1.1 NK Cell Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global NK Cell Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global NK Cell Therapy Overall Market Size
2.1 Global NK Cell Therapy Market Size: 2022 VS 2029
2.2 Global NK Cell Therapy Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top NK Cell Therapy Players in Global Market
3.2 Top Global NK Cell Therapy Companies Ranked by Revenue
3.3 Global NK Cell Therapy Revenue by Companies
3.4 Top 3 and Top 5 NK Cell Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies NK Cell Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 NK Cell Therapy Players in Global Market
3.6.1 List of Global Tier 1 NK Cell Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 NK Cell Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global NK Cell Therapy Market Size Markets, 2022 & 2029
4.1.2 NK Cell Therapies
4.1.3 NK Cell Directed Antibodies
4.2 By Type - Global NK Cell Therapy Revenue & Forecasts
4.2.1 By Type - Global NK Cell Therapy Revenue, 2018-2023
4.2.2 By Type - Global NK Cell Therapy Revenue, 2024-2029
4.2.3 By Type - Global NK Cell Therapy Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global NK Cell Therapy Market Size, 2022 & 2029
5.1.2 Cancer
5.1.3 Gastrointestinal Diseases
5.1.4 Others
5.2 By Application - Global NK Cell Therapy Revenue & Forecasts
5.2.1 By Application - Global NK Cell Therapy Revenue, 2018-2023
5.2.2 By Application - Global NK Cell Therapy Revenue, 2024-2029
5.2.3 By Application - Global NK Cell Therapy Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global NK Cell Therapy Market Size, 2022 & 2029
6.2 By Region - Global NK Cell Therapy Revenue & Forecasts
6.2.1 By Region - Global NK Cell Therapy Revenue, 2018-2023
6.2.2 By Region - Global NK Cell Therapy Revenue, 2024-2029
6.2.3 By Region - Global NK Cell Therapy Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America NK Cell Therapy Revenue, 2018-2029
6.3.2 US NK Cell Therapy Market Size, 2018-2029
6.3.3 Canada NK Cell Therapy Market Size, 2018-2029
6.3.4 Mexico NK Cell Therapy Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe NK Cell Therapy Revenue, 2018-2029
6.4.2 Germany NK Cell Therapy Market Size, 2018-2029
6.4.3 France NK Cell Therapy Market Size, 2018-2029
6.4.4 U.K. NK Cell Therapy Market Size, 2018-2029
6.4.5 Italy NK Cell Therapy Market Size, 2018-2029
6.4.6 Russia NK Cell Therapy Market Size, 2018-2029
6.4.7 Nordic Countries NK Cell Therapy Market Size, 2018-2029
6.4.8 Benelux NK Cell Therapy Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia NK Cell Therapy Revenue, 2018-2029
6.5.2 China NK Cell Therapy Market Size, 2018-2029
6.5.3 Japan NK Cell Therapy Market Size, 2018-2029
6.5.4 South Korea NK Cell Therapy Market Size, 2018-2029
6.5.5 Southeast Asia NK Cell Therapy Market Size, 2018-2029
6.5.6 India NK Cell Therapy Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America NK Cell Therapy Revenue, 2018-2029
6.6.2 Brazil NK Cell Therapy Market Size, 2018-2029
6.6.3 Argentina NK Cell Therapy Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa NK Cell Therapy Revenue, 2018-2029
6.7.2 Turkey NK Cell Therapy Market Size, 2018-2029
6.7.3 Israel NK Cell Therapy Market Size, 2018-2029
6.7.4 Saudi Arabia NK Cell Therapy Market Size, 2018-2029
6.7.5 UAE NK Cell Therapy Market Size, 2018-2029
7 NK Cell Therapy Companies Profiles
7.1 Nektar Therapeutics
7.1.1 Nektar Therapeutics Company Summary
7.1.2 Nektar Therapeutics Business Overview
7.1.3 Nektar Therapeutics NK Cell Therapy Major Product Offerings
7.1.4 Nektar Therapeutics NK Cell Therapy Revenue in Global Market (2018-2023)
7.1.5 Nektar Therapeutics Key News & Latest Developments
7.2 Innate Pharma SA
7.2.1 Innate Pharma SA Company Summary
7.2.2 Innate Pharma SA Business Overview
7.2.3 Innate Pharma SA NK Cell Therapy Major Product Offerings
7.2.4 Innate Pharma SA NK Cell Therapy Revenue in Global Market (2018-2023)
7.2.5 Innate Pharma SA Key News & Latest Developments
7.3 Affimed
7.3.1 Affimed Company Summary
7.3.2 Affimed Business Overview
7.3.3 Affimed NK Cell Therapy Major Product Offerings
7.3.4 Affimed NK Cell Therapy Revenue in Global Market (2018-2023)
7.3.5 Affimed Key News & Latest Developments
7.4 Chipscreen Biosciences
7.4.1 Chipscreen Biosciences Company Summary
7.4.2 Chipscreen Biosciences Business Overview
7.4.3 Chipscreen Biosciences NK Cell Therapy Major Product Offerings
7.4.4 Chipscreen Biosciences NK Cell Therapy Revenue in Global Market (2018-2023)
7.4.5 Chipscreen Biosciences Key News & Latest Developments
7.5 Fate Therapeutics
7.5.1 Fate Therapeutics Company Summary
7.5.2 Fate Therapeutics Business Overview
7.5.3 Fate Therapeutics NK Cell Therapy Major Product Offerings
7.5.4 Fate Therapeutics NK Cell Therapy Revenue in Global Market (2018-2023)
7.5.5 Fate Therapeutics Key News & Latest Developments
7.6 Glycostem Therapeutics
7.6.1 Glycostem Therapeutics Company Summary
7.6.2 Glycostem Therapeutics Business Overview
7.6.3 Glycostem Therapeutics NK Cell Therapy Major Product Offerings
7.6.4 Glycostem Therapeutics NK Cell Therapy Revenue in Global Market (2018-2023)
7.6.5 Glycostem Therapeutics Key News & Latest Developments
7.7 Dragonfly Therapeutics
7.7.1 Dragonfly Therapeutics Company Summary
7.7.2 Dragonfly Therapeutics Business Overview
7.7.3 Dragonfly Therapeutics NK Cell Therapy Major Product Offerings
7.7.4 Dragonfly Therapeutics NK Cell Therapy Revenue in Global Market (2018-2023)
7.7.5 Dragonfly Therapeutics Key News & Latest Developments
7.8 Kiadis Pharma
7.8.1 Kiadis Pharma Company Summary
7.8.2 Kiadis Pharma Business Overview
7.8.3 Kiadis Pharma NK Cell Therapy Major Product Offerings
7.8.4 Kiadis Pharma NK Cell Therapy Revenue in Global Market (2018-2023)
7.8.5 Kiadis Pharma Key News & Latest Developments
7.9 NantWorks
7.9.1 NantWorks Company Summary
7.9.2 NantWorks Business Overview
7.9.3 NantWorks NK Cell Therapy Major Product Offerings
7.9.4 NantWorks NK Cell Therapy Revenue in Global Market (2018-2023)
7.9.5 NantWorks Key News & Latest Developments
7.10 Nkarta Therapeutics
7.10.1 Nkarta Therapeutics Company Summary
7.10.2 Nkarta Therapeutics Business Overview
7.10.3 Nkarta Therapeutics NK Cell Therapy Major Product Offerings
7.10.4 Nkarta Therapeutics NK Cell Therapy Revenue in Global Market (2018-2023)
7.10.5 Nkarta Therapeutics Key News & Latest Developments
7.11 Fortress Biotech
7.11.1 Fortress Biotech Company Summary
7.11.2 Fortress Biotech Business Overview
7.11.3 Fortress Biotech NK Cell Therapy Major Product Offerings
7.11.4 Fortress Biotech NK Cell Therapy Revenue in Global Market (2018-2023)
7.11.5 Fortress Biotech Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
